WHO ICTRP trial
C1-inhibitor improves recovery of red blood cell transfusion in patients…
NL-OMON22958 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON22958 |
|---|---|
| Public title | C1-inhibitor improves recovery of red blood cell transfusion in patients suffering from autoimmune hemolytic anemia – an open-labeled pilot trial |
| Scientific title | C1-inhibitor improves recovery of red blood cell transfusion in patients suffering from autoimmune hemolytic anemia – an open-labeled pilot trial |
| Primary sponsor | Academic Medical Center (AMC) |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Autoimmune Hemolytic Anemia |
| Interventions | C1 inhibitor (Cinryze) |
| Registration date | Nov 14, 2019 |
| Target size | 10 |
| Secondary IDs | NL8164;METC AMC : METC 2012_266 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: